Finance

Lists
Q3 2026 earnings • in 4 days
See details
MRSH:NYSE
Marsh & McLennan Companies Inc
USD 175,76
-0,52%
(-0,91) 1D
USD 175,76
0,00% (0,00)
After hours
Closed: 9 Okt., 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRSH...
Open
USD 175,64
High
USD 177,79
Low
USD 175,41
Mkt. cap
83,87 mjd
Avg. vol.
2,70 m
Volume
1,97 m
52-wk high
USD 198,49
52-wk low
USD 156,60
Beta
0,59
Shares outstanding
477,21 m
No. of employees
95 k
Open
USD 175,64
High
USD 177,79
Low
USD 175,41
Mkt. cap
83,87 mjd
Avg. vol.
2,70 m
Volume
1,97 m
52-wk high
USD 198,49
52-wk low
USD 156,60
Beta
0,59
Shares outstanding
477,21 m
No. of employees
95 k
News stories
From web sources and news partners
Profile
Marsh & McLennan Companies, Inc., trading as Marsh McLennan and Marsh, is an American professional services firm headquartered in New York City, with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and management consulting. Its four main operating companies are Marsh, which offers risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services; Marsh Re, a reinsurance intermediary and advisor; Mercer, which provides consulting to employers for health insurance, retirement plans, and pension plans; and Oliver Wyman, including Lippincott and NERA Economic Consulting, which provides consulting services. In 2024, risk and insurance services contributed a total of 63% of revenues and 71% of operating profit, while consulting contributed 37% of revenues and 29% of operating profit. It is the largest insurance broker worldwide. The company is ranked 175th on the Fortune 500 and 267th on the Forbes Global 2000. Wikipedia
About Marsh & McLennan Companies Inc
CEOJohn Q. Doyle
Employees95 k
Founded1905
HeadquartersNew York Stad, New York, Verenigde State van Amerika
Sector-
Analyst ratings
Based on 17 analysts giving stock ratings to MRSH in the past 3 months
Hold
Buy
5
Hold
11
Sell
1
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for MRSH in the last 3 months.
Highest
Current USD 175,76
USD 234,00 (+33,14%)
Average
USD 200,07 (+13,83%)
Lowest
USD 180,00 (+2,41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yaron Kinar
Mizuho Securities
Hold
Maintained
USD 190,00
+8,1%
10/07/2026
Alex Scott
Barclays
Buy
Maintained
USD 206,00
+17,2%
10/07/2026
Bob Huang
Morgan Stanley
Hold
Maintained
USD 180,00
+2,4%
10/06/2026
Brian Meredith
UBS
Buy
Maintained
USD 222,00
+26,3%
10/06/2026
Pablo Singzon
J.P. Morgan
Buy
Maintained
USD 215,00
+22,3%
10/01/2026
Hans Engel
Erste Group
Buy
Initiated
-
-
09/08/2026
Matthew Heimermann
Citi
Hold
Maintained
USD 200,00
+13,8%
08/31/2026
Meyer Shields
KBW
Hold
Maintained
USD 202,00
+14,9%
08/27/2026
Michael Zaremski
BMO Capital
Hold
Maintained
USD 203,00
+15,5%
08/25/2026
Harry Fong
Roth MKM
Hold
Maintained
USD 200,00
+13,8%
07/22/2026
David Motemaden
Evercore ISI
Buy
Maintained
USD 234,00
+33,1%
07/22/2026
Rowland Mayor
RBC Capital
Hold
Maintained
USD 200,00
+13,8%
07/21/2026
Elyse Greenspan
Wells Fargo
Hold
Maintained
USD 188,00
+7%
07/22/2026
Robert Cox CFA
Goldman Sachs
Hold
Maintained
USD 197,00
+12,1%
07/21/2026
Joshua Shanker
Bank of America Securities
Sell
Reiterated
USD 182,00
+3,6%
07/21/2026
Adam Klauber
William Blair
Hold
Maintained
-
-
07/21/2026
Paul Newsome
Piper Sandler
Hold
Maintained
USD 182,00
+3,6%
07/15/2026
Ryan Tunis
Cantor Fitzgerald
Buy
Maintained
USD 218,00
+24%
07/09/2026
Jimmy Bhullar
J.P. Morgan
Buy
Reiterated
USD 226,00
+28,6%
03/05/2026
Gregory Peters
Raymond James
Buy
Upgraded
USD 225,00
+28%
02/17/2026
Next call oor 4 dae
Do. 15 Okt., 14:30
Fiscal period
Q3 2026
- / USD 1,97
Revenue / Est. (USD)
- / 6,64 mjd
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
6,35 mjd
6,60 mjd
7,60 mjd
7,40 mjd
Cost of goods sold
3,84 mjd
3,78 mjd
4,05 mjd
4,09 mjd
Cost of revenue
3,84 mjd
3,78 mjd
4,05 mjd
4,09 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
1,29 mjd
1,13 mjd
1,70 mjd
1,36 mjd
Total operating expenses
5,13 mjd
4,92 mjd
5,75 mjd
5,46 mjd
Operating income
1,22 mjd
1,68 mjd
1,85 mjd
1,95 mjd
Other non operating income
-
-
-
-
EBT including unusual items
1,01 mjd
1,06 mjd
1,58 mjd
1,70 mjd
EBT excluding unusual items
1,01 mjd
1,46 mjd
1,63 mjd
1,71 mjd
Income tax expense
253,00 m
222,00 m
395,00 m
411,00 m
Effective tax rate
25,05%
21,02%
24,98%
24,15%
Other operating expenses
1,29 mjd
1,13 mjd
1,70 mjd
1,36 mjd
Net income
747,00 m
821,00 m
1,15 mjd
1,27 mjd
Net profit margin
11,76%
12,45%
15,08%
17,10%
Earnings per share
1,85
2,12
3,29
2,96
Interest and investment income
25,00 m
21,00 m
17,00 m
8,00 m
Interest expense
-237,00 m
-235,00 m
-240,00 m
-250,00 m
Net interest expenses
-212,00 m
-214,00 m
-223,00 m
-242,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,45 mjd
1,91 mjd
2,08 mjd
2,18 mjd
Gain or loss from assets sale
-2,00 m
4,00 m
-
-7,00 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme